Hong Kong · SFC › People
SFC licence history
Back to top ↑| Firm | Role | Regulated activities | From | To |
|---|---|---|---|---|
| GOLDMAN SACHS (ASIA) L.L.C.高盛(亞洲)有限責任公司 | Licensed representative | Type 1, Type 4 | 12 May 2014 | 18 Feb 2015 |
Directorships of Hong Kong listed companies
Back to top ↑| Company | Position | From | To |
|---|---|---|---|
| Zylox-Tonbridge Medical Technology Co., Ltd.歸創通橋醫療科技股份有限公司2190 | Non-Executive Director | 18 May 2022 | present (as of 24 Dec 2025) |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.四川科倫博泰生物醫藥股份有限公司6990 | Non-Executive Director | 25 Feb 2022 | present (as of 24 Dec 2025) |
Sources: Webb-site archive (Enigma database). Status checked with: SFC monthly report; SFC register snapshot; Webb-site archive (Enigma database). As of: 31 Oct 2026.
History comes from the Webb-site archive and is updated from public data. It may lag the official register, so check the SFC for the current position. Report an error.